Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-Critical Coronary Artery Disease

This study is enrolling participants by invitation only.

Sponsor:

Information provided by:

Vanderbilt University

ClinicalTrials.gov Identifier:

NCT00868855

First received: March 19, 2009

Last updated: March 24, 2009

Last verified: March 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)